Comparison of the Antithrombotic Effects of FK633, GPIIb/IIIa Antagonist, and Aspirin in a Guinea Pig Thrombosis Model - Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients

By Aoki T.   Cox D.   Senzaki K.   Seki J.   Tanaka A.   Takasugi H.   Motoyama Y.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 129-136

Elsevier

Access to resources Recommend Favorite

Antiplatelet and Antithrombotic Effects of Orbofiban, a New Orally Active GPIIb/IIIa Antagonist, in Guinea Pigs

By Ogawa T.   Sugidachi A.   Naganuma H.   Asai F.  

Thrombosis Research, Vol. 97, Iss. 5, 2000-03 ,pp. : 307-315

Elsevier

Access to resources Recommend Favorite

Intranasal Antiplatelet/ Antithrombotic Efficacy of a Novel Platelet GPIIB/IIIA Receptor Antagonist DMP755 - a model for in vivo evaluation of antithrombotic agents

By Mousa S.A.   Mu D.-X.   Hussain M.A.  

Thrombosis Research, Vol. 92, Iss. 3, 1998-11 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

DISSOCIATION BETWEEN THE ANTI-AGGREGATORY & ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN IIb 3 (GPIIb/IIIa) ANTAGONISTS, c7E3 AND DMP728

By Tsao P.W.   Forsythe M.S.   Mousa S.A.  

Thrombosis Research, Vol. 88, Iss. 2, 1997-10 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

Dissociation Between the Anti-Aggregatory & Anti-Secretory Effects of Platelet Integrin IIb 3 (Gpiib/iiia) Antagonists, c7E3 and DMP728

By Tsao P.W.   Forsythe M.S.   Mousa S.A.  

Thrombosis Research, Vol. 89, Iss. 2, 1998-01 ,pp. : 97-97

Elsevier

Access to resources Recommend Favorite